News & Media

May 12, 2022 - Zambon Announces Attendance at American Thoracic Society (ATS) 2022 Annual Meeting
Download press release
April 26, 2022 - Zambon to present data on lung transplantation trends and survival rates in Europe at ISHLT 2022
Download press release
April 21, 2022 - Zambon Receives U.S. FDA Breakthrough Therapy Designation for CMS I-neb® in Patients with Non-Cystic Fibrosis Bronchiectasis (NCFB)
Download press release
September 8, 2021 - Positive Results from Phase 3 PROMIS-I Study of CMS I-neb^® in Patients with Non-Cystic Fibrosis Bronchiectasis Presented at European Respiratory Society (ERS) Annual Meeting
Read more
April 29, 2021 - Key data on economic impact of BOS presented at ISHLT 2021
Download press release